Xtant Medical Holdings, Inc. (XTNT)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Development, Manufacture and Marketing of Orthopedic Medical Products & Devices	117.27M	91.30M	57.97M	55.26M	53.34M
Development, Manufacture and Marketing of Orthopedic Medical Products & Devices Growth	28.44%	57.50%	4.90%	3.61%	-17.54%
Total	117.27M	91.30M	57.97M	55.26M	53.34M
Total Growth	28.44%	57.50%	4.90%	3.61%	-17.54%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
United States	105.52M	85.86M	57.16M	54.57M	52.15M
United States Growth	22.89%	50.21%	4.75%	4.65%	-16.40%
Rest of World	11.75M	5.44M	807.00K	693.00K	1.19M
Rest of World Growth	115.92%	574.23%	16.45%	-41.76%	-48.37%
Total	117.27M	91.30M	57.97M	55.26M	53.34M
Total Growth	28.44%	57.50%	4.90%	3.61%	-17.54%

Source: S&P Global Market Intelligence.